Nobivac Ducat

Country: United Kingdom

Bahasa: Inggeris

Sumber: VMD (Veterinary Medicines Directorate)

Bahan aktif:

Feline calicivirus, Feline viral rhinotracheitis virus

Boleh didapati daripada:

MSD Animal Health UK Limited

Kod ATC:

QI06AD03

INN (Nama Antarabangsa):

Feline calicivirus, Feline viral rhinotracheitis virus

Borang farmaseutikal:

Lyophilisate for suspension for injection

Jenis preskripsi:

POM-V - Prescription Only Medicine – Veterinarian

Kumpulan terapeutik:

Cats

Kawasan terapeutik:

Live Viral Vaccine

Status kebenaran:

Authorized

Tarikh kebenaran:

2004-10-18

Ciri produk

Revised: March 2023
AN: 00697/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobivac Ducat lyophilisate and solvent for suspension for injection,
for cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose (1 ml) of reconstituted vaccine contains:
ACTIVE SUBSTANCES:
Live attenuated feline calicivirus, strain F9:

10
4.6
PFU
2
.
Live attenuated feline rhinotracheitis virus, strain G2620A:

10
4.8
TCID
50
1
;
1
TCID
50
: Tissue Culture Infectious Dose 50%
2
PFU: Plaque-Forming Units
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lyophilisate and solvent for suspension for injection.
Lyophilisate: off-white pellet.
Solvent: clear colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of cats to reduce the clinical signs caused by
infection with feline
rhinotracheitis virus (FVR) and feline calicivirus (FCV) infections.
Onset of immunity: 4 weeks.
Duration of immunity: 1 year.
4.3
CONTRAINDICATIONS
See section 4.7.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccination at six weeks of age has been proven to be safe.
Vaccinate healthy animals only.
Revised: March 2023
AN: 00697/2022
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals:
Care should be taken that aerosol is not formed when vaccinating the
cat as nasal or
oral exposure could result in clinical respiratory signs including
lethargy and malaise.
For the same reason, the cat should be prevented from licking the
injection site.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals:
In case of accidental self-injection, seek medical advice immediately
and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Cats:
Very common
(> 1 animal / 10 animals treated):
Injection si